From: The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
Variables | Average | Standard deviation | P-value | |
---|---|---|---|---|
PCT (first day) | Vitamin C receiver | 0.8303 | 2.27549 | 0.93 |
Placebo receiver | 0.0772 | 0.07805 | ||
PCT (tenth day) | Vitamin C receiver | 0.7947 | 2.26754 | 0.98 |
Placebo receiver | 0.0430 | 0.05738 | ||
ESR (first day) | Vitamin C receiver | 38.7647 | 23.08281 | 0.685 |
Placebo receiver | 35.6250 | 20.81306 | ||
ESR )tenth day) | Vitamin C receiver | 33.800 | 27.7699 | 0.730 |
Placebo receiver | 37.2143 | 24.70185 | ||
CRP (first day) | Vitamin C receiver | 53.933 | 29.2708 | 0.5 |
Placebo receiver | 46.4312 | 31.9452 | ||
CRP (tenth day) | Vitamin C receiver | 29.1429 | 26.7491 | 0.63 |
Placebo receiver | 24.8571 | 19.2181 | ||
WBC (first day) | Vitamin C receiver | 8.3341 | 2.85633 | 0.57 |
Placebo receiver | 7.7833 | 2.88245 | ||
WBC (tenth day) | Vitamin C receiver | 7.0867 | 2.30799 | 0.92 |
Placebo receiver | 7.1743 | 2.77657 |